• Cancer Center Research Programs

    Huntsman Cancer Institute at the University of Utah (HCI) is a National Cancer Institute-Designated Comprehensive Cancer Center. The Cancer Center Support Grant (CCSG) provides funding for four research programs, each focused on a specialized aspect of basic, translational, and clinical cancer research performed by more than 135 members of our Cancer Center. These programs promote scientific excellence through coordinated, broad-based transdisciplinary research.

  • Cancer Center Directory

    Huntsman Cancer Institute has over 200 cancer research teams representing more than 20 academic departments at the University of Utah. All Cancer Center members contribute to the mission of Huntsman Cancer Institute through their participation in cancer research. Cancer Center members must be faculty at the University of Utah who conduct cancer research as a major professional focus. Our Cancer Center members conduct laboratory, clinical, translational, and population-based cancer research, and collaborate broadly with one another to amplify the impact of our work.

  • Shared Resources

    The Shared Resources at HCI and the University of Utah are funded by a combination of the Cancer Center Support Grant (CCSG), HCI institutional funds, other University of Utah funding sources, and charge-back for services.

  • Disease Oriented Research Teams (DOTs)

    HCI leadership has made a strategic commitment to develop disease oriented research teams (DOTs) as a mechanism to enhance cancer focus, transdisciplinary integration, and collaboration. The ultimate objective of the DOT program is to maximize the impact of HCI discoveries on cancer patients.

  • Research Labs and Groups

    The collaborative research approach between doctors and scientists, with an emphasis on investigating the genetic basis of cancer, makes HCI one of the leading cancer research organizations in the country.

  • Clinical Trials

    The key to finding new and better treatments for cancer lies in research. The HCI Clinical Trials Office (CTO) continually develops new approaches to help cancer patients live longer and better lives. Patient participation in clinical trials is an essential factor in this process.

  • High Risk Cancer Research Clinics and Studies

    The High Risk Cancer Research Clinics provide information for investigations into the genetics and inheritance of cancer. They provide education, and in some cases cancer screening services, for individuals and families with an increased risk of developing cancer. Through these clinics, eligible participants may enroll in cancer research studies. Physicians, genetic counselors, research coordinators, and other support personnel provide a multidisciplinary approach to patient care.

  • Faculty Recruitment

    HCI continuously searches for world-class research and clinical faculty.

  • Training and Education

    Educating the next generation of cancer researchers and physicians is one of the goals at HCI. Our training opportunities bring together students, faculty, and staff in an atmosphere of learning and collaboration between a wide range of research disciplines.